AZN : Summary for Astrazeneca PLC Common Stock - Yahoo Finance

U.S. Markets close in 3 hrs 8 mins

AstraZeneca PLC (AZN)


NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
25.65-0.36 (-1.40%)
As of 12:52 PM EST. Market open.
People also watch:
GSKNVSSNYLLYBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close26.01
Open26.06
Bid25.63 x 1000
Ask25.64 x 900
Day's Range25.55 - 26.05
52 Week Range25.55 - 35.04
Volume5,202,196
Avg. Volume6,267,903
Market Cap64.22B
Beta0.56
PE Ratio (TTM)26.32
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.90 (3.48%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • AstraZeneca (AZN) Presents Tagrisso Data at Medical Meeting
    Zacks3 hours ago

    AstraZeneca (AZN) Presents Tagrisso Data at Medical Meeting

    AstraZeneca plc (AZN) presented positive data from a randomized phase III study (AURA3) on its lung cancer drug Tagrisso at a lung cancer conference in Vienna, Austria.

  • AstraZeneca PLC (ADR) (AZN) Relocating Jobs At U.K. Division
    Insider Monkeyyesterday

    AstraZeneca PLC (ADR) (AZN) Relocating Jobs At U.K. Division

    AstraZeneca plc (ADR) (NYSE:AZN) plans to cut some back office jobs in the U.K. as the company works toward cost-cutting and operation consolidation. The latest job cut by the company in the U.K. will be at its finance division located in Alderley Park, England. Some 280 employees work at the company’s finance office in Alderley […]

  • TheStreet.comyesterday

    AstraZeneca Reports Positive Lung Cancer Drug Trial Results

    AstraZeneca reported optimistic results for its lung cancer drug Tagrisso in a trial, saying it improved progression-free survival by nearly six months.